Align Technology, US0162551016

Align Technology Stock - Buyback program advances as sector lags this week

19.06.2026 - 18:29:36 | ad-hoc-news.de

Align Technology continues to execute on its $1.0 billion share repurchase authorization while its stock tracks broader medical-device and dental peers over the past week. A look at the buyback, recent performance and where Align sits in the sector.

Align Technology, US0162551016
Align Technology, US0162551016

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 18:26 CET. Details in the imprint.

Align Technology (US0162551016) is working through its previously announced $1.0 billion share repurchase authorization while its stock performance this week roughly mirrors a softer tone across dental and medical-device names, according to recent market data and company disclosures. Company news aggregation citing Align releases

Go deeper

All news and data on Align Technology stock

Further background, regulatory filings and price data on Align Technology stock are available in the dedicated topic section on ad-hoc-news.de and via the company’s investor relations site.

Buyback remains a key capital lever

Align Technology disclosed a $1.0 billion stock repurchase program in April 2025 and has since executed several tranches, including a $200 million open-market component and a further $200 million phase expected to run into late 2026. IR release archive referencing repurchase plans

The company has funded the buybacks from cash on hand, positioning repurchases as a way to offset dilution from share-based compensation and return excess capital while continuing to invest in product development and its digital dentistry ecosystem.

How Align compares with peers this week

On a trailing five-day basis into 06/18/2026, Align shares around $182 have broadly tracked the medical-device and dental space, which has shown muted moves amid uncertainty over procedure volumes and consumer spending on discretionary dental treatments. Recent quote and performance snapshot

With a market capitalization near $13.0 billion and a price-to-earnings ratio just above 29 based on recent pricing, the stock continues to trade at a premium to many diversified medtech names but closer to faster-growing dental and aesthetic peers.

What the company sells

Align Technology generates most of its revenue from the Invisalign clear aligner system, used by orthodontists and dentists to straighten teeth, alongside its iTero intraoral scanners and exocad CAD/CAM software, which support digital workflows for diagnosis, treatment planning and restorative dentistry.

Where the stock trades today

Align Technology shares (US0162551016) trade on the Nasdaq at $182.08 as of 06/18/2026, 16:00 ET.

Key facts on Align Technology stock

  • Company: Align Technology, Inc.
  • ISIN: US0162551016
  • WKN: 590375
  • Ticker: ALGN
  • Venue: Nasdaq
  • Price (as of 06/18/2026, 16:00 ET): 182.08 USD
  • Market cap: 13.04 billion USD (as of 06/18/2026)
  • Sector / Industry: Health Care / Medical Devices
  • Index membership: Standard & Poor's 500 index
  • Next earnings date: not officially scheduled

More on Align Technology stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US0162551016 | ALIGN TECHNOLOGY | boerse | 69584186 | bgmi